• In a study of hypogonadal men, testosterone treated to normal men were 56% less likely to die than no treatment men.
• Study findings “support growing evidence that testosterone replacement is safe with respect to prostate cancer.”
• Testosterone replacement may have gone from bad to good or very good, even in high-risk vascular groups like diabetics.
1. Vigen R, O’Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310:1829-1836.
2. Sharma R, Oni OA, Gupta K, et al. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J. 2015;36:2706-2715.
3. Kaplan AL, Hu JC. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Urology. 2013;82:321-326.
4. Dhindsa S, Prabhakar S, Sethi M, et al. Frequent occurrence of hypogonadotrophic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004;89:5462-5468.
5. Farias JM, Tinetti M, Khoury M, Umpierrez GE. Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab. 2014;99:4698-4703.
6. Busko M, Vega CP. Erectile dysfunction drugs improve survival in diabetic men. July 29, 2015. Medscape Internal Medicine.
7. Costarella CE, Stallone JN, Rutecki GW, Whittier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther. 1999;277:34-39.